Weekly regimen of paclitaxel and carboplatin as first-line che 11 cell lung cancer (NSCLC): Results of a phase II study

A. Rozzi, C. Nardoini, M. Corona, M. R. Restuccia, T. Falbo, G. Lanzetta

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Weekly regimen of paclitaxel and carboplatin as first-line che 11 cell lung cancer (NSCLC): Results of a phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences